In this scenario, the stockholders would be set-up for a class action suit against both the BOD and the company getting the patent. The BOD knows this.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.